These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7040867)

  • 1. Use of estrogen in treatment of familial hemorrhagic telangiectasia.
    Harrison DF
    Laryngoscope; 1982 Mar; 92(3):314-20. PubMed ID: 7040867
    [No Abstract]   [Full Text] [Related]  

  • 2. Epistaxis due to hereditary hemorrhagic telangiectasia.
    Zohar Y; Strauss M
    Laryngoscope; 1995 Apr; 105(4 Pt 1):445-6. PubMed ID: 7794350
    [No Abstract]   [Full Text] [Related]  

  • 3. Some unusual experiences with oestrin therapy.
    Jowett RE
    J Laryngol Otol; 1968 Jan; 82(1):69-71. PubMed ID: 5635231
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hereditary telangiectasia.
    Bradbeer WH
    J Laryngol Otol; 1969 Jul; 83(7):667-9. PubMed ID: 4893944
    [No Abstract]   [Full Text] [Related]  

  • 5. Modified Young's procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia.
    Gluckman JL; Portugal LG
    Laryngoscope; 1994 Sep; 104(9):1174-7. PubMed ID: 8072369
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen and progesterone receptors in hereditary hemorrhagic telangiectasia.
    Richtsmeier W; Weaver G; Streck W; Jacobson H; Dewell R; Olson J
    Otolaryngol Head Neck Surg; 1984 Oct; 92(5):564-70. PubMed ID: 6438587
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.
    Ichimura K; Kikuchi H; Imayoshi S; Dias MS
    Auris Nasus Larynx; 2016 Aug; 43(4):429-32. PubMed ID: 26739947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of severe recurrent epistaxis due to hereditary hemorrhagic telangiectasia using regional facial cutaneous flaps.
    Strauss M; Zohar Y; Laurian N
    J Laryngol Otol; 1985 Apr; 99(4):373-7. PubMed ID: 4009036
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical 22-case study of hereditary hemorrhagic telangiectasia subjects undergoing nasal dermoplasty].
    Kikuchi H; Imayoshi S; Yamauchi T; Ichimura K
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Feb; 115(2):108-11. PubMed ID: 22568130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.
    Yaniv E; Preis M; Shevro J; Nageris B; Hadar T
    Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of epistaxis in Osler-Weber-Rendu disease: recurrence of telangiectases within a nasal skin graft.
    McCabe WP; Kelly AP
    Plast Reconstr Surg; 1972 Aug; 50(2):114-8. PubMed ID: 4558109
    [No Abstract]   [Full Text] [Related]  

  • 13. A modified technique for septodermoplasty in hereditary hemorrhagic telangiectasia.
    Rimmer J; Lund VJ
    Laryngoscope; 2014 Jan; 124(1):67-9. PubMed ID: 23832829
    [No Abstract]   [Full Text] [Related]  

  • 14. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia.
    Choi JW; Joo YH; Jeong WS; Jang YJ
    Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
    Parambil JG; Woodard TD; Koc ON
    Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic graft in the management of severe epistaxis due to hereditary haemorrhagic telangiectasia.
    Laurian N; Kalmanovitch M; Shimberg R
    J Laryngol Otol; 1979 Jun; 93(6):589-95. PubMed ID: 469391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of significant estrogen and progesterone receptor expression in nasal telangiectasias in hereditary hemorrhagic telangiectasia: an immunohistochemical analysis.
    Eivazi B; Werner JA; Roessler M; Negm H; Teymoortash A
    Acta Otolaryngol; 2012 Jan; 132(1):86-9. PubMed ID: 22185213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
    Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C
    Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorrhagic telangiectasia.
    Ananthasubramaniam G; Sathyavathi R; Chitra N
    J Assoc Physicians India; 1981 May; 29(5):425-7. PubMed ID: 7298565
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases.
    McCaffrey TV; Kern EB; Lake CF
    Arch Otolaryngol; 1977 Nov; 103(11):627-30. PubMed ID: 921594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.